Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
33
QTRX Quote, Financials, Valuation and Earnings
Last price:
$6.50
Seasonality move
:
-4.38%
Day range:
$6.26 - $6.46
52-week range:
$4.05 - $12.41
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.98x
P/B ratio:
0.94x
Volume:
362K
Avg. volume:
751.3K
1-year change:
-40.17%
Market cap:
$297.1M
Revenue:
$137.4M
EPS (TTM):
-$2.33
Analysts' Opinion
-
Consensus RatingQuanterix Corp. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $7.00, Quanterix Corp. has an estimated upside of 10.06% from its current price of $6.36.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $6.00 representing 100% downside risk from its current price of $6.36.
Fair Value
-
According to the consensus of 3 analysts, Quanterix Corp. has 10.06% upside to fair value with a price target of $7.00 per share.
QTRX vs. S&P 500
-
Over the past 5 trading days, Quanterix Corp. has underperformed the S&P 500 by -3.04% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Quanterix Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Quanterix Corp. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Quanterix Corp. reported revenues of $40.2M.
Earnings Growth
-
Quanterix Corp. earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Quanterix Corp. reported earnings per share of -$0.73.
Enterprise value:
202.4M
EV / Invested capital:
--
Price / LTM sales:
1.98x
EV / EBIT:
--
EV / Revenue:
1.55x
PEG ratio (5yr expected):
-0.02x
EV / Free cash flow:
-2.97x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$70.7M
Return On Assets:
-23.46%
Net Income Margin (TTM):
-73.47%
Return On Equity:
-30.04%
Return On Invested Capital:
-26.87%
Operating Margin:
-74.94%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $116.6M | $133.8M | $130.2M | $35.8M | $40.2M | |
| Gross Profit | $66.7M | $72.9M | $70.7M | $20.2M | $17.2M | |
| Operating Income | -$44.8M | -$56.9M | -$97.1M | -$11.7M | -$30.2M | |
| EBITDA | -$36.7M | -$45M | -$83.2M | -$9.6M | -$23.5M | |
| Diluted EPS | -$1.01 | -$1.06 | -$2.33 | -$0.22 | -$0.73 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $459.4M | $386.8M | $381M | $367M | $233.3M | |
| Total Assets | $510.8M | $446.7M | $429M | $411M | $444.1M | |
| Current Liabilities | $31.2M | $28.6M | $35.2M | $36.5M | $77.4M | |
| Total Liabilities | $55.3M | $73.9M | $75.7M | $72.1M | $129.6M | |
| Total Equity | $455.5M | $372.8M | $353.4M | $338.9M | $314.5M | |
| Total Debt | $22.8M | $42.2M | $38.3M | $33.9M | $32.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$17.1M | -$36.8M | -$65.1M | -$5.7M | -$41.2M | |
| Cash From Investing | -$128.6M | -$136.3M | $74.2M | -$12.4M | -$52.9M | |
| Cash From Financing | $3.2M | $616K | -$145K | $144K | $150K | |
| Free Cash Flow | -$20.4M | -$42M | -$68.2M | -$6.6M | -$41.9M | |
QTRX
Sector
Market Cap
$297.1M
$28.1M
Price % of 52-Week High
51.26%
50%
Dividend Yield
0%
0%
Shareholder Yield
-0.44%
-1.54%
1-Year Price Total Return
-40.17%
-17.67%
Beta (5-Year)
1.006
0.503
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$6.52
200-day SMA
Buy
Level
$5.76
Bollinger Bands (100)
Buy
Level
4.78 - 6.68
Chaikin Money Flow
Sell
Level
-2.9M
20-day SMA
Sell
Level
$7.07
Relative Strength Index (RSI14)
Sell
Level
40.89
ADX Line
Sell
Level
33.23
Williams %R
Buy
Level
-92.0732
50-day SMA
Buy
Level
$6.32
MACD (12, 26)
Buy
Level
1.77
25-day Aroon Oscillator
Sell
Level
-68
On Balance Volume
Sell
Level
-3.1M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.2598)
Buy
CA Score
(Annual)
Level (0.4927)
Buy
Beneish M-Score
(Annual)
Level (-2.4211)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-1.1037)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.
Stock Forecast FAQ
In the current month, QTRX has received 0 Buy ratings 3 Hold ratings, and 0 Sell ratings. The QTRX average analyst price target in the past 3 months is $7.00.
-
Where Will Quanterix Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Quanterix Corp. share price will rise to $7.00 per share over the next 12 months.
-
What Do Analysts Say About Quanterix Corp.?
Analysts are divided on their view about Quanterix Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Quanterix Corp. is a Sell and believe this share price will drop from its current level to $6.00.
-
What Is Quanterix Corp.'s Price Target?
The price target for Quanterix Corp. over the next 1-year time period is forecast to be $7.00 according to 3 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is QTRX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Quanterix Corp. is a Hold. 3 of 3 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of QTRX?
You can purchase shares of Quanterix Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Quanterix Corp. shares.
-
What Is The Quanterix Corp. Share Price Today?
Quanterix Corp. was last trading at $6.50 per share. This represents the most recent stock quote for Quanterix Corp.. Yesterday, Quanterix Corp. closed at $6.36 per share.
-
How To Buy Quanterix Corp. Stock Online?
In order to purchase Quanterix Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get QTRX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
QTRX
Sector
P/E ratio
--
23.88x
PEG ratio
-0.02x
-0.01x
P/B ratio
0.94x
1.82x
Price / LTM sales
1.98x
1.59x
Growth Metrics
QTRX
Sector
Revenue growth
12.34%
4.73%
Earnings growth
-235.04%
11.11%
Revenue (5-year growth)
19.36%
6.46%
Earnings forecast
-$0.69
-$0.18
Profitability
QTRX
Sector
Profitability FY 2024
$83.1M
$3.6M
Return on invested capital
-26.87%
-31.77%
Return on assets
-23.46%
-28.18%
Return on equity
-30.04%
-37.47%
Earnings Date
Last Earnings Date
Nov
10
Next Earnings Date
Mar
16
Estimated Next Earnings Date
Feb
9
Balance Sheet
QTRX
Sector
Total cash
$134.8M
$26.3M
Short term investments
$232.4M
$26M
Total assets
$411.7M
$76.9M
Long term debt
$32.1M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 2
Corcept Therapeutics, Inc. [CORT] is up 5.11% over the past day.
Buy
75
AXSM alert for Jan 2
Axsome Therapeutics, Inc. [AXSM] is down 3.83% over the past day.
Sell
50
NUTX alert for Jan 2
Nutex Health, Inc. [NUTX] is down 9.63% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
